ATE444075T1 - Pharmazeutische zusammensetzung enthaltend bacillus coagulans und simethicon zur behandlung von gastrointestinalen störungen - Google Patents

Pharmazeutische zusammensetzung enthaltend bacillus coagulans und simethicon zur behandlung von gastrointestinalen störungen

Info

Publication number
ATE444075T1
ATE444075T1 AT06425217T AT06425217T ATE444075T1 AT E444075 T1 ATE444075 T1 AT E444075T1 AT 06425217 T AT06425217 T AT 06425217T AT 06425217 T AT06425217 T AT 06425217T AT E444075 T1 ATE444075 T1 AT E444075T1
Authority
AT
Austria
Prior art keywords
treatment
pharmaceutical composition
simethicon
composition containing
gastrointestinal disorders
Prior art date
Application number
AT06425217T
Other languages
English (en)
Inventor
Luigi Mercuri
Original Assignee
Dmg Italia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dmg Italia Srl filed Critical Dmg Italia Srl
Application granted granted Critical
Publication of ATE444075T1 publication Critical patent/ATE444075T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
AT06425217T 2005-10-26 2006-03-29 Pharmazeutische zusammensetzung enthaltend bacillus coagulans und simethicon zur behandlung von gastrointestinalen störungen ATE444075T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000531A ITRM20050531A1 (it) 2005-10-26 2005-10-26 Dispositivo medico comprendente lactobacilli e simeticone per il trattamento delle patologie gastrointestinali.

Publications (1)

Publication Number Publication Date
ATE444075T1 true ATE444075T1 (de) 2009-10-15

Family

ID=37517205

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06425217T ATE444075T1 (de) 2005-10-26 2006-03-29 Pharmazeutische zusammensetzung enthaltend bacillus coagulans und simethicon zur behandlung von gastrointestinalen störungen

Country Status (10)

Country Link
EP (1) EP1782818B1 (de)
AT (1) ATE444075T1 (de)
CY (1) CY1109668T1 (de)
DE (1) DE602006009455D1 (de)
ES (1) ES2333744T3 (de)
IT (1) ITRM20050531A1 (de)
ME (1) ME01754B (de)
PL (1) PL1782818T3 (de)
PT (1) PT1782818E (de)
RS (1) RS51158B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
EP3341408A4 (de) * 2015-08-27 2019-04-24 The General Hospital Corporation Verfahren und zusammensetzungen zur hemmung der entgiftungsreaktion
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
JP2002522393A (ja) * 1998-08-07 2002-07-23 ガネデン バイオテック， インコーポレイテッド 共生乳酸産生細菌を使用する、栄養材料の溶解度を増大するための方法
IT1306201B1 (it) * 1999-01-14 2001-05-30 Giuliani Spa Composizione adatta quale integratore alimentare e per il trattamentoterapeutico di disturbi intestinali e di alterazioni della flora
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic

Also Published As

Publication number Publication date
DE602006009455D1 (de) 2009-11-12
EP1782818B1 (de) 2009-09-30
PT1782818E (pt) 2009-12-24
ITRM20050531A1 (it) 2007-04-27
CY1109668T1 (el) 2014-08-13
EP1782818A1 (de) 2007-05-09
RS51158B (sr) 2010-10-31
PL1782818T3 (pl) 2010-03-31
ME01754B (de) 2010-10-31
ES2333744T3 (es) 2010-02-26

Similar Documents

Publication Publication Date Title
NO20072906L (no) Metode for forhindring eller behandling av respiratoriske infeksjoner og akutt otitis media hos barn
ATE502596T1 (de) Schmales zahnimplantat und zugeordnete teile
DK1773361T4 (da) Sammensætning baseret på probiotiske bakterier og anvendelse deraf til forebyggelse og/eller behandling af respiratoriske sygdomme
ATE544457T1 (de) Verfahren zur behandlung bzw. prävention systemischer entzündungen
PL1943219T3 (pl) Inhibitory białka aktywującego 5-lipooksygenazę (flap)
CL2007003155A1 (es) Compuestos derivados de 3,7-diazabiciclo[3.3.0]octano o 3,7-diazabiciclo[3.3.1]nonano, moduladores de receptores nicotinicos neuronales; composicion farmaceutica; y uso en el tratamiento de trastornos del snc.
DE502007002101D1 (de) Arzneimittel mit Dobesilat-Calcium zur Behandlung und Prophylaxe von Sehnenerkrankungen
DE602005019856D1 (de) Mittel zur behandlung von hyperlipidämie mit pitavastatinen und eicosapentaensäure
IL189104A (en) Pharmaceutical preparation containing lasalazide or sodium balasalazide for use in the treatment of gastrointestinal disorders.
ATE528012T1 (de) Uronsäure und probiotika
SG10201407403UA (en) Treatments For Gastrointestinal Disorders
CL2018001420A1 (es) Tratamiento de trastornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma. (divisional solicitud 201701853)
TW200517107A (en) Novel formulation
WO2008042101A3 (en) Probiotics for use in reducing the incidence and duration of illness
ATE517907T1 (de) 1-kestose zur behandlung von allergie und atopischer dermatitis
HUE050758T2 (hu) Glutamátmoduláló szerek mentális rendellenességek kezelésére
ATE546149T1 (de) Prävention und behandlung von allergischer diarrhöe
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
CY1109668T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει βακιλλο bacillus coagulans και σιμεθικονη για τη θεραπεια γαστρεντερικων παθολογιων
DE602004000842D1 (de) Zusammensetzungen zur Behandlung von Angstzuständen und damit verbundenen Erkrankungen
ATE546159T1 (de) Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen enthaltend langwirksame beta-2-agonisten und wenigstens einen weiteren wirkstoff
ATE506069T1 (de) Verfahren und zusammensetzung zur modulation des systemischen entzündlichen reaktionssyndroms (sirs)
DE112005001443T5 (de) Mittel gegen Tuberkulose zur Behandlung und Prophylaxe
WO2006044548A3 (en) Clopidogrel compositions
ATE418558T1 (de) Darstellung von 1-aza-2-oxadibenzoäe,hüazulenen und deren verwendung bei der herstellung pharmazeutischer formulierungen zur behandlung und prävention von krankheiten und erkrankungen des zentralen nervensystems

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties